EMA convenes vaccine researchers, developers, public health experts and regulators for a two-day hybrid workshop — , from the Agency's Amsterdam office — to review the latest evidence on pneumococcal vaccine immunogenicity and efficacy.
Dates and format
- Dates: Monday 16 – Tuesday 17 November 2026, 09:00–17:00 CET both days
- Format: hybrid workshop — in person at EMA's Amsterdam office, or online via WebEx
- Venue: European Medicines Agency, Domenico Scarlattilaan 6, 1083 HS Amsterdam, Netherlands
- Organizer: European Medicines Agency
- Agenda reference: EMA/236032/2026, first published 22 October 2026
What it covers
The workshop's stated aim is to bring researchers, vaccine developers, public health experts and regulators together to review the latest evidence on pneumococcal vaccines and brainstorm how to optimise current vaccines and support the development of next-generation ones. Alessandra Buoninfante of EMA chairs the first day; the published speaker list includes Simon Jochems of Leiden University Medical Center, James Paton of the University of Adelaide and Adam Finn of the University of Bristol, with Bill Hausdorff of PATH speaking on day two. It joins EMA's wider run of autumn vaccine and biologics events, alongside the EudraVigilance Signal Detection Forum in December.
Who should attend
Vaccine and biologics regulatory affairs leads tracking EMA's scientific thinking on pneumococcal disease, clinical and preclinical scientists working on next-generation conjugate vaccines, and public health and pharmacovigilance staff following the evidence base regulators are weighing. Readers tracking the vaccine conference circuit more broadly can also see the World Vaccine Congress Washington, and the full events directory lists everything we have verified.
Frequently asked questions
When does the EMA pneumococcal vaccines workshop run?
Two days: Monday 16 and Tuesday 17 November 2026, 09:00-17:00 CET each day, per EMA's own event page.
Is it in person or online?
Hybrid. EMA describes it as a workshop at its Amsterdam office with a WebEx option for remote attendees; check EMA's event page for the current registration and joining links.
Who is speaking?
EMA's Alessandra Buoninfante chairs day one. Listed speakers include Simon Jochems (Leiden University Medical Center), James Paton (University of Adelaide) and Adam Finn (University of Bristol), with Bill Hausdorff (PATH) on day two, per the EMA-published agenda (reference EMA/236032/2026).
What will the workshop cover?
EMA's stated aim is to bring researchers, vaccine developers, public health experts and regulators together to review the latest evidence on pneumococcal vaccines and discuss optimising current vaccines and supporting development of next-generation ones.
Sources & further reading
- EMA. Immunogenicity and efficacy of pneumococcal vaccines, 16-17/11/2026. ema.europa.eu
- EMA. Agenda, Immunogenicity and efficacy of pneumococcal vaccines (EMA/236032/2026). ema.europa.eu
Event details are published by the organizer and can change. Confirm dates, format, fees and access with EMA before making plans. Verified via WebSearch corroboration against the organizer's own event page and agenda PDF (direct fetch was blocked this session) — last checked 27 October 2026.
